Pharmaceutical Case Study
A newly established Contract Pharma company has acquired its first manufacturing plant from a major global pharmaceutical entity. The ambitious project involves migrating over 15 critical systems and data within a tight one-year timeline, including SAP and network infrastructure. Timely completion is imperative to avoid substantial financial penalties and potential business disruptions.
Project Context
The initial SAP strategy centered on cloning or carving out the production enterprise system from the seller's infrastructure. Despite extensive negotiations with internal stakeholders, it became evident that the seller would not support the clone approach. This realization occurred after three months under the Transition Services Agreement, during which no formal planning had been initiated for any of the IT workstreams.
Engagement Approach and Solution
The Chief Operating Officer enlisted us to develop a viable IT strategy aimed at recovering lost time. Our analysis determined that the initial SAP carve-out plan would have delivered less than 10% of the required functionality and would have taken as long as starting anew with a greenfield implementation. Following a thorough evaluation of various implementation vendors, we chose new partners capable of offering a generic pharmaceutical template based on core ECC. This solution minimizes configuration needs while ensuring efficient implementation.
Achievements
Services Offered
Testimonial
“In addition to their technical knowledge, TMG’s deep understanding of FDA regulations ensured that we maintained GMP compliance during execution and provided guidance to our Quality Assurance group.”
Jim Scandura
Chief Operating Officer
Avara Pharmaceutical Services
Let’s Get Connected
Do you also want to experience growth? Feel free to contact us and discuss your requirements. Our team is always ready to help you with quality small business consulting, and auditing services.
